missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Mirikizumab Recombinant Human Monoclonal Antibody, Invitrogen™
Human Recombinant Monoclonal Antibody
Brand: Invitrogen MA542172
338.10 EUR valid until 2025-03-16
Use promo code "24070" to get your promotional price.
This item is not returnable.
View return policy
Description
Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.
Mirikizumab is a humanized IgG4 monoclonal antibody that targets p19 subunit of IL-23. Currently, mirikizumab is being developed for a variety of immune diseases, including psoriasis, UC, and Crohn's disease (CD). Among them, the treatment of moderate to severe plaque psoriasis is in phase III clinical trials.
Specifications
Mirikizumab | |
Recombinant Monoclonal | |
Unconjugated | |
LY-3074828 | |
Human IL23A | |
100 μg | |
Primary | |
-20° C, Avoid Freeze/Thaw Cycles | |
Liquid | |
Chemical |
ELISA, SDS-Page | |
1.76 mg/mL | |
PBS with no preservative; pH 7.5 | |
Human | |
Protein A | |
RUO | |
Chemical | |
Antibody | |
IgG4 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Mirikizumab Recombinant Human Monoclonal Antibody, Invitrogen™ > 100 μg; Unconjugated
Spot an opportunity for improvement?Share a Content Correction